Characterization of the Constitutively Active V2 Receptor Mutants Conferring NSIAD

被引：0
|
作者：
Julie, T. [1 ,2 ,3 ]
Mohammed, A. [2 ,3 ]
Bruno, R. [4 ]
Christiane, M. [2 ,3 ]
Thierry, D. [2 ,3 ]
Denis, M. [1 ,2 ,3 ]
机构：
[1] CHU, Montpellier, France
[2] UM 1, IGF, CNRS, UMR 5203, Montpellier, France
[3] UM 1, INSERM 661, Montpellier, France
[4] HFME, Lyon, France
来源：
PEDIATRIC NEPHROLOGY | 2010年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
938
引用
收藏
页码：1983 / 1983
页数：1
相关论文
共 50 条
  • [41] Functional and Behavioral Characterization of a Constitutively Active Mutant (V175D) Form of the Human 5-HT2A Receptor
    Powell, Susan
    Halberstadt, Adam
    McOmish, Caitlin
    Risbrough, Victoria
    Geyer, Mark
    Gingrich, Jay
    Burstein, Ethan
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S168 - S169
  • [42] CONSTITUTIVELY ACTIVE BETA-2-ADRENERGIC RECEPTOR
    COTECCHIA, S
    SAMAMA, P
    LEFKOWITZ, RJ
    CLINICAL RESEARCH, 1992, 40 (02): : A310 - A310
  • [43] Vasopressin V2 Receptor/Bioligand Interactions
    Cezary Czaplewski
    Rajmund Kaźmierkiewicz
    Jerzy Ciarkowski
    Letters in Peptide Science, 1998, 5 : 333 - 335
  • [44] Tolvaptan, Vasopressin V2 Receptor Antagonist
    Inomata, Takayuki
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (09) : S135 - S135
  • [45] An expanded V2 receptor retention signal
    Le Gouill, C
    Innamorati, G
    Birnbaumer, M
    FEBS LETTERS, 2002, 532 (03) : 363 - 366
  • [46] Vasopressin V2 receptor/bioligand interactions
    Czaplewski, C
    Kazmierkiewicz, R
    Ciarkowski, J
    LETTERS IN PEPTIDE SCIENCE, 1998, 5 (5-6): : 333 - 335
  • [47] Identification and characterization of constitutively active Smad2 mutants: Evaluation of formation of Smad complex and subcellular distribution
    Funaba, M
    Mathews, LS
    MOLECULAR ENDOCRINOLOGY, 2000, 14 (10) : 1583 - 1591
  • [48] Vasopressin V2 receptor/bioligand interactions
    Cezary Czaplewski
    Rajmund Kaźmierkiewicz
    Jerzy Ciarkowski
    Letters in Peptide Science, 1998, 5 : 333 - 335
  • [49] Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation (vol 33, pg 2413, 2013)
    Bagarova, Jana
    Vonner, Ashley J.
    Armstrong, Kelli A.
    Boergermann, Jan
    Lai, Carol S. C.
    Deng, Donna Y.
    Beppu, Hideyuki
    Alfano, Ivan
    Filippakopoulos, Panagis
    Morrell, Nicholas W.
    Bullock, Alex N.
    Knaus, Petra
    Mishina, Yuji
    Yu, Paul B.
    MOLECULAR AND CELLULAR BIOLOGY, 2017, 37 (19)
  • [50] Characterization of 2 novel proteins that interact with the constitutively active form of the Drosophila dpp receptor tkv
    Stapleton, M
    OConnor, M
    DEVELOPMENTAL BIOLOGY, 1997, 186 (02) : A67 - A67
12345